Iressa Versus Docetaxel (Taxotere)

Clinical trial NCT00076388 · COMPLETED

Trial details

NCT number: NCT00076388
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2004-02-01
Primary completion: 2007-03-01
Enrollment: 1440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.